Accessibility Menu
Coloplast A/s logo

Coloplast A/s(OTC) CLPBF

Current Price$64.00
Market Cap$14.42BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2004)-36%
5 Year-59%
1 Year-29%
1 Month+12%
Coloplast A/s last closing stock price
MetricPriceDate
Last closeUSD 64.002026-07-21
Coloplast A/s stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+6.56%USD 60.062026-07-14
1 month+12.28%USD 57.002026-06-18
3 month-2.51%USD 65.642026-04-22
Year to date-22.54%USD 82.622025-12-24
1 year-28.91%USD 90.032025-07-21
3 year-41.54%USD 109.472023-07-20
5 year-58.52%USD 154.312021-07-22
Since inception-35.95%USD 99.922004-12-06

Coloplast A/s Financials at a Glance

Market Cap

$14.42BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

DKK 28.04B

Net Income (TTM)

DKK 2.10B

EPS (TTM)

$1.44

P/E Ratio

44.39

Dividend

$3.58

Beta (Volatility)

0.21 (Low)

Price

$64.00

Volume

90

Open

$64.00

Previous Close

$64.00

Daily Range

$64.00 - $64.00

52-Week Range

$56.81 - $98.58

Estimated Earnings Date

Aug 18, 2026

CLPBF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Coloplast A/s

Coloplast A/S is a leading global company specializing in the development and sale of intimate healthcare products and services. Founded in 1954 and headquartered in Humlebæk, Denmark, the company operates across various segments, including Chronic Care, Continence Care, and Advanced Wound Dressings.

Products and Services
  • Ostomy care products, including SenSura Mio and Brava accessories
  • Continence care solutions like SpeediCath catheters and Peristeen irrigation systems
  • Advanced wound care products, including Biatain Silicone and Comfeel dressings
Growth Outlook
  • Revenue growth of 2.5% year-over-year in the latest quarter
  • Strong demand for continence care products driving market expansion
  • Investment in R&D expected to enhance product offerings and market reach
Financial Highlights
  • Recent quarterly revenue of 7.09 billion DKK, reflecting stable performance
  • Trailing twelve months (TTM) net profit margin of 7.5%, indicating profitability
  • Dividend yield of 5.6%, showcasing commitment to returning value to shareholders
Coloplast A/S has established itself as a key player in the healthcare sector, focusing on innovative solutions for patients with intimate healthcare needs. The company's diverse product portfolio and commitment to research and development position it well for future growth. Recent financial performance highlights a stable revenue stream and a solid profit margin, which may appeal to potential investors. The strong dividend yield further emphasizes the company's dedication to shareholder value, making it an attractive option for those interested in the healthcare industry.
AI Generated • Jul 21, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

16,907

CEO

Lars Søren Rasmussen, MBA

Website

www.coloplast.com

Headquarters

Humlebæk, ZE 3050, DK

CLPBF Financials

Key Financial Metrics (TTM)

Gross Margin

58.60%

Operating Margin

26.47%

Net Income Margin

7.51%

Return on Equity

14.23%

Return on Capital

19.55%

Return on Assets

4.51%

Earnings Yield

2.25%

Dividend Yield

5.59%

Payout Ratio

2.46%

Stock Overview

Market Cap

$14.42BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

225.37M

Volume

90

Avg. Volume

1.89K

Financials (TTM)

Gross Profit

DKK 17.24B

Operating Income

DKK 7.40B

EBITDA

DKK 11.68B

Operating Cash Flow

DKK 7.59B

Capital Expenditure

-DKK 1.56B

Free Cash Flow

DKK 6.03B

Cash & ST Invst.

DKK 1.07B

Total Debt

DKK 24.25B

Coloplast A/s Performance Analysis

Coloplast A/s annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-09-30DKK 3,282,245,3135.2%
20232023-09-30DKK 3,507,139,8256.9%
20242024-09-30DKK 3,928,316,42412.0%
20252025-09-30DKK 4,124,716,4405.0%
Coloplast A/s sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-06-300.4%
Q42025-09-30-0.2%
Q12025-12-311.4%
Q22026-03-310.7%
Coloplast A/s annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-09-30DKK 3.21-11.6%
20232023-09-30DKK 3.18-1.2%
20242024-09-30DKK 3.262.8%
20252025-09-30DKK 2.39-26.9%
Coloplast A/s sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-06-30-11.9%
Q42025-09-308.7%
Q12025-12-3159.8%
Q22026-03-31-169.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

DKK 7.09B

+2.3%

Gross Profit

DKK 3.05B

-35.6%

Gross Margin

42.95%

N/A

Market Cap

$14.42BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$851.19K

N/A

Employees

16,945

N/A

Net Income

-DKK 972.01M

-206.6%

EBITDA

DKK 5.15B

+139.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

DKK 1.07B

+46.5%

Total Debt

DKK 24.25B

-0.0%

Accounts Receivable

DKK 4.98B

-9.3%

Inventory

DKK 3.95B

+3.9%

Long Term Debt

DKK 22.02B

+27.1%

Short Term Debt

DKK 2.23B

-67.8%

Return on Assets

4.51%

N/A

Return on Invested Capital

18.25%

N/A

Free Cash Flow

DKK 1.06B

+146.1%

Operating Cash Flow

DKK 1.47B

+97.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SBHMYSino Biopharmaceutical Limited
$12.68+0.00%
SUVPFSartorius AG
$256.25+5.10%
SDMHFSartorius Stedim Biotech S.A.
$191.50+0.00%
SAUHYStraumann Holding AG
$11.83-3.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TAT&T
$23.04+0.04%
SMCISuper Micro Computer
$30.56+0.20%
AALAmerican Airlines Group
$14.79-0.03%
NOKNokia
$10.28-0.03%

Questions About CLPBF

What is the current price of Coloplast A/s?

Coloplast A/s is trading at $64.00 per share.

What is the 52-week range for Coloplast A/s?

Over the past 52 weeks, Coloplast A/s has traded between $56.81 and $98.58.

How much debt does Coloplast A/s have?

As of the most recent reporting period, Coloplast A/s reported total debt of DKK 3.74B.

How much cash does Coloplast A/s have on hand?

Coloplast A/s reported DKK 164.52M in cash and cash equivalents in its most recent financial results.

What is Coloplast A/s’s dividend yield?

Coloplast A/s currently has a dividend yield of 5.59%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services